West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 246,800 | 226,700 | 230,000 | 230,000 | 221,700 |
| Marketable Securities | N/A | N/A | N/A | N/A | 7,500 |
| Receivables | 195,900 | 209,600 | 208,700 | 185,700 | 198,200 |
| Inventories | 185,700 | 187,900 | 187,500 | 176,900 | 176,700 |
| Income taxes - deferred | 18,400 | 16,800 | 16,300 | 15,900 | 9,300 |
| Other current assets | 32,700 | 44,400 | 44,100 | 42,200 | 30,100 |
| TOTAL | $679,500 | $685,400 | $686,600 | $650,700 | $643,500 |
| Non-Current Assets | |||||
| PPE Net | 694,800 | 709,200 | 712,000 | 711,700 | 682,000 |
| Investments And Advances | 61,800 | 60,400 | 59,400 | 60,900 | 59,100 |
| Intangibles | 153,800 | 160,100 | 161,300 | 162,500 | 161,900 |
| Other Non-Current Assets | 83,400 | 89,600 | 88,900 | 85,800 | 118,000 |
| TOTAL | $993,800 | $1,019,300 | $1,021,600 | $1,020,900 | $1,021,000 |
| Total Assets | $1,673,300 | $1,704,700 | $1,708,200 | $1,671,600 | $1,664,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 91,400 | 94,500 | 98,400 | 108,000 | 86,300 |
| Accrued Expenses | 51,600 | 51,700 | 41,800 | 59,100 | 55,800 |
| Other current liabilities | 54,200 | 57,800 | 60,800 | 53,000 | 51,400 |
| TOTAL | $242,500 | $221,200 | $227,600 | $236,900 | $246,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 315,500 | 359,300 | 390,700 | 371,300 | 381,100 |
| aiOther Non-Current Liabilities | 126,900 | 132,000 | 135,600 | 138,100 | 180,300 |
| TOTAL | $460,700 | $510,900 | $546,000 | $528,300 | $581,000 |
| Total Liabilities | $703,200 | $732,100 | $773,600 | $765,200 | $827,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,070 | 70,765 | 70,670 | 70,339 | 69,835 |
| Common Shares | 17,800 | 17,800 | 17,700 | 17,600 | 17,500 |
| Retained earnings | 878,700 | 855,500 | 825,000 | 805,000 | 788,600 |
| Other shareholders' equity | -71,500 | -34,900 | -34,000 | -32,200 | -69,300 |
| TOTAL | $970,100 | $972,600 | $934,600 | $906,400 | $836,700 |
| Total Liabilities And Equity | $1,673,300 | $1,704,700 | $1,708,200 | $1,671,600 | $1,664,500 |